澄清「疾管署接管賽諾菲公司自費四價疫苗，致該公司無法交貨予醫療機構」之錯誤訊息- 衛生福利部
https://www.mohw.gov.tw/cp-17-45356-1.html
Lin mark this message contains misinformation
｜originally written by Lin
替換之四價疫苗與先前進口之自費四價疫苗「無關」：經積極與賽諾菲公司協商，該公司同意以最快可供貨之24.3萬劑流感疫苗替換，因為該公司尚餘之三價流感疫苗數量不足，故部分以四價流感疫苗替換之，但該替換之四價疫苗與先前進口之自費四價疫苗無關。
References
https://www.mohw.gov.tw/cp-17-45356-1.htmlThe content above by Cofacts message reporting chatbot and crowd-sourced fact-checking community is licensed under Creative Commons Attribution-ShareAlike 4.0 (CC BY-SA 4.0), the community name and the provenance link for each item shall be fully cited for further reproduction or redistribution.